GLENMARK₹2,166.60-1.45%
Value & Investment Index
VIIVII Detail
90 days · zone the stock traded inMultiples vs Peers
Quality Scores
Versus Its Own History
P/E · P/B percentile bandsScenario analysis
stated assumptions, shown workingsGLENMARK valuation summary
Glenmark Pharmaceuticals Ltd trades at 43.0 times trailing earnings. Return on equity is 3.9% and return on capital employed is 6.5%. The dividend yield is 0.22%.
| P/E | 43.0 |
|---|---|
| ROE | 3.9% |
| ROCE | 6.5% |
| Dividend yield | 0.22% |